Zobrazeno 1 - 8
of 8
pro vyhledávání: '"de Albuquerque LZ"'
Autor:
da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 Andre Cavalcanti Street, 5 Floor, Annex Building, Rio de Janeiro, 20231050, Brazil. jesse.silva@inca.gov.br., de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 Andre Cavalcanti Street, 5 Floor, Annex Building, Rio de Janeiro, 20231050, Brazil., Rodrigues MES; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 Andre Cavalcanti Street, 5 Floor, Annex Building, Rio de Janeiro, 20231050, Brazil., Thuler LCS; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 Andre Cavalcanti Street, 5 Floor, Annex Building, Rio de Janeiro, 20231050, Brazil., de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 Andre Cavalcanti Street, 5 Floor, Annex Building, Rio de Janeiro, 20231050, Brazil.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jul; Vol. 206 (2), pp. 359-367. Date of Electronic Publication: 2024 Apr 21.
Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study.
Autor:
da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Clinical Oncology, Galeao Air Force Hospital, Rio de Janeiro, Rio de Janeiro, Brazil., de Souza BSW; Dasa Oncology, Hospital Nove de Julho, São Paulo, São Paulo, Brazil., de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Aleixo SB; Department of Clinical Oncology, Evangelical Hospital of Cachoeiro de Itapemirim, Cachoeiro de Itapemirim, Espírito Santo, Brazil., Resende GADS; Department of Clinical Oncology, Amazonia Integrated Research Center, Manaus, Amazonas, Brazil., de Oliveira DGB; Department of Clinical Oncology, Hospital Santa Izabel-Santa Casa da Bahia, Salvador, Bahia, Brazil., Dos Santos EN; Department of Clinical Oncology, Amil Integrated Oncology Care, São Paulo, Sao Paulo, Brazil., Nogueira-Rodrigues A; Department of General Medicine UFMG, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Brazilian Society of Clinical Oncology, São Paulo, São Paulo, Brazil., Clara RO; Brazilian Society of Clinical Oncology, São Paulo, São Paulo, Brazil., Gaui MFD; Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil., Mota ACA; Department of Clinical Oncology, AMO Clinic-DASA, Salvador, Bahia, Brazil., de Lima VCC; Department of Medical Oncology, A C Camargo Cancer Center, São Paulo, São Paulo, Brazil., Rosa DD; Brazilian Society of Clinical Oncology, São Paulo, São Paulo, Brazil.; Department of Clinical Oncology, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil., Munhoz RR; Oncology Center-Hospital Sírio Libanes, São Paulo, São Paulo, Brazil., Morbeck IAP; Oncoclinicas Group of the Federal District, São Paulo, São Paulo, Brazil., Gelatti ACZ; Oncoclinicas Group of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.; Brazilian Group of Thoracic Tumors, Porto Alegre, Rio Grande do Sul, Brazil., Mathias CMC; Oncoclinicas Group of Bahia, Salvador, Bahia, Brazil., de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil.
Publikováno v:
PloS one [PLoS One] 2023 Dec 21; Vol. 18 (12), pp. e0295597. Date of Electronic Publication: 2023 Dec 21 (Print Publication: 2023).
Autor:
de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil. lucas_zanetti1996@hotmail.com., da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil., Dos Santos ALS; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil., Rodrigues IP; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil., de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2023 Jun; Vol. 17 (3), pp. 686-693. Date of Electronic Publication: 2022 Feb 11.
Autor:
da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Rodrigues FR; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Bastos NC; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Small IA; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Barroso EBC; Clinical Oncology Section, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Cordero FL; Gynecologic Oncology Section, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Fernandes DS; Gynecologic Oncology Section, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Paulino E; Clinical Oncology Section, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Publikováno v:
PloS one [PLoS One] 2023 May 18; Vol. 18 (5), pp. e0285447. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Autor:
da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil. jesse.silva@inca.gov.br.; Gynecologic Oncology Section, Brazilian National Cancer Institute, Rio de Janeiro, Brazil. jesse.silva@inca.gov.br., de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Rodrigues FR; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., de Mesquita GG; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Chaves CBP; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Gynecologic Oncology Section, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Bonamino MH; Immunology and Tumor Biology Program, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Vice-Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil., de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Publikováno v:
BMC cancer [BMC Cancer] 2021 Dec 07; Vol. 21 (1), pp. 1306. Date of Electronic Publication: 2021 Dec 07.
Autor:
da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Rodrigues FR; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., de Mesquita GG; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Fernandes PV; Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Thuler LCS; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Nov 09; Vol. 11, pp. 636716. Date of Electronic Publication: 2021 Nov 09 (Print Publication: 2021).
Autor:
de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Thuler LCS; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Pecego AC; Hospital Infection Control Committee, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Rodrigues LOR; Hospital Infection Control Committee, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., da Conceição MS; Hospital Infection Control Committee, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Garrido MM; Hospital Infection Control Committee, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Quintella Mendes GL; Section of Clinical Oncology, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Mendes Pereira ACP; Section of Anesthesiology, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Soares MA; Program of Oncovirology, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil., Viola JPB; Program of Immunology and Tumor Biology, Brazilian National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil.
Publikováno v:
PloS one [PLoS One] 2020 Oct 26; Vol. 15 (10), pp. e0241261. Date of Electronic Publication: 2020 Oct 26 (Print Publication: 2020).
Autor:
da Silva JMC; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil; Programa de Pós Graduação em Patologia, Universidade Federal Fluminense, Niterói, Brazil., Campos MLA; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., Teixeira MP; Laboratório de Endocrinologia Experimental, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Programa de Pós-Graduação em Endocrinologia Experimental, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., da Silva Faustino R; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., Aleixo RC; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., Cavalcante FJP; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., Gomes LRO; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., de Albuquerque LZ; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., das Neves Azevedo A; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil., Cabral VR; Faculdade de Educação, Departamento de Fundamentos Pedagógicos, Universidade Federal Fluminense, Niterói, Brazil., Paiva LS; Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil; Programa de Pós Graduação em Patologia, Universidade Federal Fluminense, Niterói, Brazil. Electronic address: lupaiva@id.uff.br.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2020 Sep; Vol. 86, pp. 106772. Date of Electronic Publication: 2020 Jul 13.